# Crawford & Co: financial statements, quarterly

CRD-A · NYSE · CIK 25475 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crd-a.md) · [Financials](/companies/crd-a/financials.md) · [Filings](/companies/crd-a/filings.md) · [Insiders](/companies/crd-a/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/crd-a/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [342](/filings/0000950170-24-120774.md) | [309 d](/filings/0001193125-26-116011.md) | [313](/filings/0000950170-25-063584.md) | [327](/filings/0000950170-25-102033.md) | [343](/filings/0001193125-25-262728.md) | [358 d](/filings/0001193125-26-116011.md) | [323](/filings/0001193125-26-204372.md) | [335](/filings/0001193125-26-330643.md) | [333](/filings/0001193125-25-262728.md) | [320 d](/filings/0001193125-26-116011.md) | [320](/filings/0001193125-26-204372.md) | [330](/filings/0001193125-26-330643.md) |
| Cost of revenue | $m | [242](/filings/0000950170-24-120774.md) | [230 d](/filings/0001193125-26-116011.md) | [226](/filings/0000950170-25-063584.md) | [235](/filings/0000950170-25-102033.md) | [249](/filings/0001193125-25-262728.md) | [263 d](/filings/0001193125-26-116011.md) | [233](/filings/0001193125-26-204372.md) | [236](/filings/0001193125-26-330643.md) | [239](/filings/0001193125-25-262728.md) | [235 d](/filings/0001193125-26-116011.md) | [232](/filings/0001193125-26-204372.md) | [235](/filings/0001193125-26-330643.md) |
| Selling, general and administrative | $m | [74.4](/filings/0000950170-24-120774.md) | [74.9 d](/filings/0001193125-26-116011.md) | [77.3](/filings/0000950170-25-063584.md) | [72.3](/filings/0000950170-25-102033.md) | [71.5](/filings/0001193125-25-262728.md) | [78.5 d](/filings/0001193125-26-116011.md) | [74.6](/filings/0001193125-26-204372.md) | [78.3](/filings/0001193125-26-330643.md) | [69.4](/filings/0001193125-25-262728.md) | [71.8 d](/filings/0001193125-26-116011.md) | [76.1](/filings/0001193125-26-204372.md) | [69.7](/filings/0001193125-26-330643.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [4.6](/filings/0000950170-24-120774.md) | [3.8 d](/filings/0001193125-26-116011.md) | [3.6](/filings/0000950170-25-063584.md) | [4.3](/filings/0000950170-25-102033.md) | [4.7](/filings/0001193125-25-262728.md) | [4.3 d](/filings/0001193125-26-116011.md) | [3.9](/filings/0001193125-26-204372.md) | [3.9](/filings/0001193125-26-330643.md) | [3.8](/filings/0001193125-25-262728.md) | [3.1 d](/filings/0001193125-26-116011.md) | [2.6](/filings/0001193125-26-204372.md) | [2.9](/filings/0001193125-26-330643.md) |
| Income tax | $m | [6.8](/filings/0000950170-24-120774.md) | [(0.2) d](/filings/0001193125-26-116011.md) | [1.0](/filings/0000950170-25-063584.md) | [4.5](/filings/0000950170-25-102033.md) | [5.3](/filings/0001193125-25-262728.md) | [3.7 d](/filings/0001193125-26-116011.md) | [2.5](/filings/0001193125-26-204372.md) | [5.8](/filings/0001193125-26-330643.md) | [5.8](/filings/0001193125-25-262728.md) | [0.8 d](/filings/0001193125-26-116011.md) | [2.4](/filings/0001193125-26-204372.md) | [6.2](/filings/0001193125-26-330643.md) |
| Net income | $m | [12.3](/filings/0000950170-24-120774.md) | [(0.8) d](/filings/0001193125-26-116011.md) | [2.8](/filings/0000950170-25-063584.md) | [8.6](/filings/0000950170-25-102033.md) | [9.5](/filings/0001193125-25-262728.md) | [5.7 d](/filings/0001193125-26-116011.md) | [6.7](/filings/0001193125-26-204372.md) | [7.8](/filings/0001193125-26-330643.md) | [12.4](/filings/0001193125-25-262728.md) | [(7.2) d](/filings/0001193125-26-116011.md) | [4.9](/filings/0001193125-26-204372.md) | [13.4](/filings/0001193125-26-330643.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [49.2](/filings/0000950170-24-120774.md) | [58.4](/filings/0001193125-26-116011.md) | [45.2](/filings/0000950170-25-063584.md) | [46.7](/filings/0000950170-25-102033.md) | [52.3](/filings/0001193125-25-262728.md) | [55.4](/filings/0001193125-26-330643.md) | [57.4](/filings/0001193125-26-204372.md) | [58.5](/filings/0001193125-26-330643.md) | [68.8](/filings/0001193125-25-262728.md) | [64.1](/filings/0001193125-26-330643.md) | [54.5](/filings/0001193125-26-204372.md) | [69.4](/filings/0001193125-26-330643.md) |
| Current assets | $m | [380](/filings/0000950170-23-059480.md) | [369](/filings/0000950170-25-030894.md) | [346](/filings/0000950170-24-051333.md) | [352](/filings/0000950170-24-090835.md) | [362](/filings/0000950170-24-120774.md) | [374](/filings/0001193125-26-116011.md) | [373](/filings/0000950170-25-063584.md) | [376](/filings/0000950170-25-102033.md) | [372](/filings/0001193125-25-262728.md) | [352](/filings/0001193125-26-330643.md) | [368](/filings/0001193125-26-204372.md) | [363](/filings/0001193125-26-330643.md) |
| Total assets | $m | [827](/filings/0000950170-23-059480.md) | [799](/filings/0000950170-25-030894.md) | [776](/filings/0000950170-24-051333.md) | [786](/filings/0000950170-24-090835.md) | [801](/filings/0000950170-24-120774.md) | [804](/filings/0001193125-26-116011.md) | [792](/filings/0000950170-25-063584.md) | [799](/filings/0000950170-25-102033.md) | [800](/filings/0001193125-25-262728.md) | [764](/filings/0001193125-26-330643.md) | [772](/filings/0001193125-26-204372.md) | [758](/filings/0001193125-26-330643.md) |
| Current liabilities | $m | [291](/filings/0000950170-23-059480.md) | [299](/filings/0000950170-25-030894.md) | [264](/filings/0000950170-24-051333.md) | [272](/filings/0000950170-24-090835.md) | [283](/filings/0000950170-24-120774.md) | [300](/filings/0001193125-26-116011.md) | [286](/filings/0000950170-25-063584.md) | [281](/filings/0000950170-25-102033.md) | [274](/filings/0001193125-25-262728.md) | [310](/filings/0001193125-26-330643.md) | [323](/filings/0001193125-26-204372.md) | [305](/filings/0001193125-26-330643.md) |
| Long-term debt | $m | not reported | [209](/filings/0000950170-24-024987.md) | not reported | not reported | not reported | [218](/filings/0000950170-25-030894.md) | not reported | not reported | not reported | [189](/filings/0001193125-26-116011.md) | not reported | not reported |
| Short-term borrowings | $m | [17.0](/filings/0000950170-23-059480.md) | [14.8](/filings/0000950170-25-030894.md) | [19.4](/filings/0000950170-24-051333.md) | [24.4](/filings/0000950170-24-090835.md) | [32.4](/filings/0000950170-24-120774.md) | [17.8](/filings/0001193125-26-116011.md) | [41.3](/filings/0000950170-25-063584.md) | [22.8](/filings/0000950170-25-102033.md) | [21.3](/filings/0001193125-25-262728.md) | [38.5](/filings/0001193125-26-330643.md) | [43.5](/filings/0001193125-26-204372.md) | [47.5](/filings/0001193125-26-330643.md) |
| Shareholders' equity | $m | [165](/filings/0000950170-23-059480.md) | [142](/filings/0000950170-25-030894.md) | [145](/filings/0000950170-24-051333.md) | [151](/filings/0000950170-24-090835.md) | [161](/filings/0000950170-24-120774.md) | [157](/filings/0001193125-26-116011.md) | [161](/filings/0000950170-25-063584.md) | [177](/filings/0000950170-25-102033.md) | [187](/filings/0001193125-25-262728.md) | [173](/filings/0001193125-26-330643.md) | [176](/filings/0001193125-26-204372.md) | [186](/filings/0001193125-26-330643.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [40.9 d](/filings/0000950170-24-120774.md) | [35.7 d](/filings/0001193125-26-116011.md) | [(19.8)](/filings/0000950170-25-063584.md) | [11.6 d](/filings/0000950170-25-102033.md) | [19.3 d](/filings/0001193125-25-262728.md) | [40.5 d](/filings/0001193125-26-116011.md) | [(13.9)](/filings/0001193125-26-204372.md) | [35.0 d](/filings/0001193125-26-330643.md) | [30.6 d](/filings/0001193125-25-262728.md) | [50.1 d](/filings/0001193125-26-116011.md) | [3.3](/filings/0001193125-26-204372.md) | [19.9 d](/filings/0001193125-26-330643.md) |
| Capital expenditure | $m | [1.4 d](/filings/0000950170-24-120774.md) | [1.5 d](/filings/0001193125-26-116011.md) | [1.5](/filings/0000950170-25-063584.md) | [(0.1) d](/filings/0000950170-25-102033.md) | [1.6 d](/filings/0001193125-25-262728.md) | [3.2 d](/filings/0001193125-26-116011.md) | [1.0](/filings/0001193125-26-204372.md) | [1.4 d](/filings/0001193125-26-330643.md) | [1.4 d](/filings/0001193125-25-262728.md) | [3.2 d](/filings/0001193125-26-116011.md) | [1.9](/filings/0001193125-26-204372.md) | [1.3 d](/filings/0001193125-26-330643.md) |
| Dividends paid | $m | [3.4 d](/filings/0000950170-24-120774.md) | [3.4 d](/filings/0001193125-26-116011.md) | [3.4](/filings/0000950170-25-063584.md) | [3.4 d](/filings/0000950170-25-102033.md) | [3.4 d](/filings/0001193125-25-262728.md) | [3.4 d](/filings/0001193125-26-116011.md) | [3.5](/filings/0001193125-26-204372.md) | [3.5 d](/filings/0001193125-26-330643.md) | [3.7 d](/filings/0001193125-25-262728.md) | [3.7 d](/filings/0001193125-26-116011.md) | [3.7](/filings/0001193125-26-204372.md) | [3.6 d](/filings/0001193125-26-330643.md) |
| Share repurchases | $m | [0.6 d](/filings/0000950170-24-120774.md) | [2.1 d](/filings/0001193125-26-116011.md) | [0.7](/filings/0000950170-25-063584.md) | [1.3 d](/filings/0000950170-25-102033.md) | [1.5 d](/filings/0001193125-25-262728.md) | [0.3 d](/filings/0001193125-26-116011.md) | [0.0](/filings/0001193125-26-204372.md) | [0.0 d](/filings/0001193125-26-330643.md) | [3.0 d](/filings/0001193125-25-262728.md) | [7.6 d](/filings/0001193125-26-116011.md) | [5.5](/filings/0001193125-26-204372.md) | [3.5 d](/filings/0001193125-26-330643.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2008-06-30) | period not labelled (2008-09-30) | period not labelled (2009-03-31) | Q2 FY2009 (2009-06-30) | Q3 FY2009 (2009-09-30) | Q1 FY2010 (2010-03-31) | Q2 FY2010 (2010-06-30) | Q3 FY2010 (2010-09-30) | Q1 FY2011 (2011-03-31) | Q2 FY2011 (2011-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [51.0](/filings/0001193125-09-170256.md) | [52.0](/filings/0000950123-09-059975.md) | [52.7](/filings/0000950123-10-047032.md) | [51.9](/filings/0000950123-10-074774.md) | [52.0](/filings/0000025475-10-000124.md) | [52.9](/filings/0000025475-11-000092.md) | [52.6](/filings/0000025475-11-000126.md) | [53.3](/filings/0000025475-10-000124.md) | [53.5](/filings/0000025475-11-000092.md) | [53.9](/filings/0000025475-11-000126.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.